Craft

Zymergen

Revenue

$16.7 M

FY, 2021

Zymergen Summary

Company Summary

Overview
Zymergen is a company that researches, develops, and manufactures microbes for industrial applications. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues inside the body or on the skin to close a wound or protect against infection. The company also integrates artificial intelligence algorithms and robotic genomics to search the microbial genome, discover new materials, commercialize new products, and improve existing bio-manufactured products.
Type
Subsidiary
Status
Active
Founded
2013
HQ
Emeryville, CA, US | view all locations
Website
http://www.zymergen.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jay Flatley

    Jay Flatley, Chief Executive Officer

    • Lincoln Germain

      Lincoln Germain, Chief Commercial Officer

    • Amanda Treleaven

      Amanda Treleaven, Chief Compliance Officer

    • Celeste Ferber

      Celeste Ferber, VP, Corporate Legal

    Operating MetricsView all

    Facility Space, sq. ft.

    262K

    FY, 2020

    Patents Pending (US)

    322

    FY, 2020

    Patent Applications (US)

    500

    FY, 2020

    LocationsView all

    2 locations detected

    • Emeryville, CA HQ

      United States

      5980 Horton Street, Suite 105

    • Emeryville, CA

      United States

      5300 Chiron Way

    Zymergen Financials

    Summary Financials

    Revenue (Q2, 2022)
    $2.6M
    Net income (Q2, 2022)
    ($116.5M)
    Cash (Q2, 2022)
    $213.6M
    EBIT (Q2, 2022)
    ($106.2M)

    Footer menu